B.C. Enforces Witnessed Dosing for Safer Supply Program

British Columbia is set to implement a pivotal change to its prescribed alternatives program as of December 30, 2023. The province will require all patients to receive their prescribed alternatives, commonly known as “safer supply” drugs, through witnessed dosing. This transition was initially announced in February but was only applied to new patients at that time. Existing patients were allowed to continue their prescriptions at home until now.

As of the end of this month, all patients will need to take their medications in the presence of a health professional. This requirement aims to better manage the distribution of hydromorphone, a key component in the program designed to help individuals struggling with opioid addiction by providing a safer alternative to toxic street drugs.

The move has sparked controversy, particularly after reports indicated that some prescribed alternatives were allegedly being diverted to the illegal market. Furthermore, there were claims that certain pharmacists offered incentives to attract patients to their services.

In defense of the program, Health Minister Josie Osborne addressed concerns, stating, “Prescribed alternatives remain one of many tools and strategies that we use to help separate people from a toxic drug supply, to help keep them alive, to access care.”

While the witnessed dosing requirement will apply broadly, there will be “limited exceptions” for specific cases, although details on these exceptions have yet to be clarified. Osborne is expected to provide further insights on these changes during a scheduled address at 1:15 PM on the same day.

The prescribed alternatives program has been a significant aspect of British Columbia’s response to the ongoing opioid crisis, which has seen a sharp increase in overdose deaths in recent years. By ensuring that patients use their medication under supervision, the province aims to mitigate risks associated with misuse and promote safer practices.

As the implementation date approaches, many are watching closely to see how these changes will impact patients and the broader fight against opioid addiction in the region. This story will be updated following Minister Osborne’s remarks.